Clinical Trial Update: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement [NA]

View source ↗

Summary

This completed clinical trial evaluated the safety and efficacy of mycophenolate mofetil in patients with systemic sclerosis (scleroderma) with lung involvement…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Systemic Sclerosis

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: University of California, San Francisco | Conditions: Scleroderma, Systemic | NA | Status: COMPLETED | Results posted: 2013-05-17